Penny Stocks on the ASX with Market Capitalizations of Up to A$200 Million

Written by Emily J. Thompson, Senior Investment Analyst

Source: Yahoo Finance

Updated: Nov 21 2025

0mins

Source: Yahoo Finance

Market Overview: The Australian market is facing volatility, leading investors to consider penny stocks for potential growth opportunities despite their speculative nature.
Actinogen Medical Limited: This pre-revenue biotech firm focuses on therapies for neurological diseases, has a market cap of A$177.83 million, and is financially stable despite increasing losses and no current revenue.
Mach7 Technologies Limited: With a market cap of A$81.06 million, this unprofitable company generates revenue from software solutions in healthcare and has appointed a new CFO to drive growth, while maintaining a stable cash runway.
Marmota Limited: Focused on mineral exploration, this pre-revenue company has a market cap of A$84.84 million, reports a net loss, but maintains financial stability with no debt and a cash runway extending beyond one year.

About the author

Emily J. Thompson

Emily J. Thompson, a Chartered Financial Analyst (CFA) with 12 years in investment research, graduated with honors from the Wharton School. Specializing in industrial and technology stocks, she provides in-depth analysis for Intellectia’s earnings and market brief reports.